As of Nov 24
| +0.0904 / +14.58%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +603.83% increase from the last price of 0.71.
The current consensus among 1 polled investment analysts is to Buy stock in Cyclacel Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.